Ulipristal acetate: A guide to its use in emergency contraception

被引：0

作者：

Scott L.J. ^{[1
]}

McKeage K. ^{[1
]}

Croxtall J.D. ^{[1
]}

机构：

[1] Adis, A Wolters Kluwer Business, North Shore 0754, Auckland, 41 Centorian Drive, Private Bag 65901, Mairangi Bay

来源：

Drugs & Therapy Perspectives | 2012年 / 28卷 / 2期

关键词：

Ulipristal;

D O I：

10.2165/11606240-000000000-00000

中图分类号：

学科分类号：

摘要：

Ulipristal acetate, the first of a new class of selective progesterone receptor modulators, is indicated for emergency contraception within 120 hours of unprotected sexual intercourse or contraceptive failure. In clinical trials, a single oral dose of ulipristal acetate was effective in preventing pregnancies in women requesting emergency contraception and provided sustained efficacy throughout the 120-hour postcoital period.

引用

页码：6 / 9

页数：3

共 11 条

[1]

McKeage K., Croxtall J.D., Ulipristal acetate: A review of its use in emergency contraception, Drugs, 71, 7, pp. 935-945, (2011)

[2]

Trussell J., Ellertson C., Von Hertzen H., Bigrigg A., Webb A., Evans M., Ferden S., Leadbetter C., Estimating the effectiveness of emergency contraceptive pills, Contraception, 67, 4, pp. 259-265, (2003)

[3]

Von Hertzen H., Piaggio G., Ding J., Chen J., Song S., Bartfai G., Ng E., Gemzell-Danielsson K., Oyunbileg A., Wu S., Cheng W., Ludicke F., Pretnar-Darovec A., Kirkman R., Mittal S., Khomassuridze A., Apter D., Peregoudov A., Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomised trial, Lancet, 360, 9348, pp. 1803-1810, (2002)

[4]

Cheng L., Gulmezoglu A.M., Piaggio G.G.P., Et al., Interventions for emergency contraception, Cochrane Database Syst Rev, 2, (2008)

[5]

EllaOne (Ulipristal Acetate 30 Mg) Summary of Product Characteristics, (2010)

[6]

Ella® (ulipristal acetate) tablet US prescribing information, Morris-town (NJ) Watson Pharma Inc., (2010)

[7]

Brache V., Cochon L., Jesam C., Et al., Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture, Hum Reprod, 25, 9, pp. 2256-2263, (2010)

[8]

Creinin M.D., Schlaff W., Archer D.F., Wan L., Frezieres R., Thomas M., Rosenberg M., Higgins J., Progesterone receptor modulator for emergency contraception: A randomized controlled trial, Obstetrics and Gynecology, 108, 5, pp. 1089-1097, (2006)

[9]

Glasier A.F., Cameron S.T., Fine P.M., Et al., Ulipristal acetate versus levonorgestrel for emergency contraception: A randomised non-inferiority trial and meta-analysis, Lancet, 375, 9714, pp. 555-562, (2010)

[10]

Fine P., Mathe H., Ginde S., Et al., Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception, Obstet Gynecol, 115, 2 PART 1, pp. 257-263, (2010)

← 1 2 →